Streetbeat News

Analyst Ratings

FND

Wedbush analyst Seth Basham maintains an Outperform rating on Floor & Decor Holdings (NYSE:FND) but lowers the price target from $110 to $90.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 1:09 pm

ZS

JMP Securities analyst Trevor Walsh has reiterated a 'Market Outperform' rating on Zscaler (NASDAQ:ZS) and maintained a price target of $225.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 1:08 pm

GOVX

GeoVax Labs, Inc. (NASDAQ:GOVX) has announced advancements in its COVID-19 vaccine and cancer therapy programs, advanced manufacturing developments, and new patents for its Ebola, Marburg, Malaria, and HIV vaccines. The company is currently conducting three Phase 2 clinical trials for its next-generation COVID-19 vaccine (GEO-CM04S1) and is preparing to announce initial data readouts from two of these trials. GeoVax has also signed a commercial license agreement with ProBioGen for its AGE1.CR.pIX® suspension cell line, which will enhance the manufacturing capabilities of its entire Modified Vaccinia Ankara (MVA)-based vaccine portfolio.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 1:06 pm

PANW

JMP Securities analyst Trevor Walsh has reiterated a 'Market Outperform' rating on Palo Alto Networks (NASDAQ:PANW) and maintained a $300 price target.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 1:06 pm

CYBR

JMP Securities analyst Trevor Walsh has reiterated a 'Market Outperform' rating on CyberArk Software (NASDAQ:CYBR) and maintained a price target of $195.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 1:04 pm

CRWD

JMP Securities analyst Trevor Walsh has reiterated a Market Outperform rating on CrowdStrike Holdings (NASDAQ:CRWD) and maintained a $235 price target.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 1:03 pm

KMPR

JMP Securities analyst Matthew Carletti maintains a Market Outperform rating on Kemper (NYSE:KMPR) but lowers the price target from $85 to $75.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 1:01 pm

SILK

8 analysts have provided ratings for Silk Road Medical (NASDAQ:SILK) in the last quarter. The average price target is $26.12, implying an upside from the current price of $6.48. This average represents a 41.96% decrease from the previous average price target of $45.00.

Portfolio Pulse from Benzinga Insights

October 24, 2023 | 1:00 pm

EXR

Analysts have provided various ratings for Extra Space Storage (EXR) in the last quarter, with 2 bullish, 3 indifferent, and 2 somewhat bearish. The average 12-month price target for EXR is $138.0, a decrease of 12.88% from the previous average of $158.40.

Portfolio Pulse from Benzinga Insights

October 24, 2023 | 1:00 pm

PSA

Analysts have provided various ratings for Public Storage (NYSE:PSA) within the last quarter, with 3 bullish, 1 somewhat bullish, and 1 indifferent. The company has an average 12-month price target of $293.0, representing a 13.82% decrease from the previous average price target of $340.00.

Portfolio Pulse from Benzinga Insights

October 24, 2023 | 1:00 pm